Clinuvel Pharmaceuticals Limited ( CLVLF) - Stock Earnings
CLVLF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | 8.7 million USD | 22.2 million USD |
| 2025Q2 | 14.5 million USD | 39.0 million USD |
| 2025Q4 | 7.0 million USD | 24.7 million USD |
CLVLF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 20.3 million USD | 52.0 million USD |
| 2024 | 23.8 million USD | 58.8 million USD |
| 2025 | 23.8 million USD | 62.5 million USD |
| 2026 Est. | — | — |
CLVLF
Price: $5.38
Dividend Yield: 0.61%
Forward Dividend Yield: 0.67%
Payout Ratio: 7.08%
Dividend Per Share: 0.04 USD
Earnings Per Share: 0.48 USD
P/E Ratio: 12.33
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 297.4 million
Average Dividend Frequency: 1
Years Paying Dividends: 9
DGR3: 30.00%
DGR5: 30.00%